TP53 and breast cancer: However, interestingly, the p53-p21-Rb pathway, which has been reported by our group to be modulated in breast CSCs to hold them in G1 [13], was not changed in the tested colon CSCs (levels of p53, p21, and pRbs did not increase as in breast cancer cells).